We are live on ! Find out more
TWA

TCI Wealth Advisors Portfolio holdings

AUM $2.31B
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-13.2%
1 Year Est. Return
+26.52%
3 Year Est. Return
+65.05%
5 Year Est. Return
+75.05%
10 Year Est. Return
+319.89%
AUM
$654M
AUM Growth
-$13.8M
Cap. Flow
+$90.3M
Cap. Flow %
13.81%
Top 10 Hldgs %
61.86%
Holding
2,649
New
341
Increased
678
Reduced
602
Closed
269

Sector Composition

Rank Sector Weight
1 Technology 5.39%
2 Healthcare 4.35%
3 Industrials 3.04%
4 Consumer Discretionary 2.88%
5 Financials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA.WS
2576
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$0 ﹤0.01%
700
MMAT
2577
DELISTED
Meta Materials Inc. Common Stock
MMAT
-45
Closed -$7K
LL
2578
DELISTED
LL Flooring Holdings, Inc.
LL
-245
Closed -$3K
CERE
2579
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-149
Closed -$5K
AIRC
2580
DELISTED
Apartment Income REIT Corp.
AIRC
$0 ﹤0.01%
8
DMTK
2581
DELISTED
DermTech, Inc. Common Stock
DMTK
$0 ﹤0.01%
77
+34
+79% +$278
YTEN
2582
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
AYX
2583
DELISTED
Alteryx Inc
AYX
-2
Closed
SPLK
2584
DELISTED
Splunk Inc
SPLK
$0 ﹤0.01%
1
-79
-99% -$8.69K
BFX
2585
DELISTED
BowFlex Inc.
BFX
-995
Closed -$4K
SIEN
2586
DELISTED
Sientra, Inc.
SIEN
-160
Closed -$4K
GERM
2587
DELISTED
Amplify Treatments, Testing and Advancements ETF
GERM
$0 ﹤0.01%
10
SGEN
2588
DELISTED
Seagen Inc. Common Stock
SGEN
$0 ﹤0.01%
1
EQRXW
2589
DELISTED
EQRx, Inc. Warrant
EQRXW
$0 ﹤0.01%
4
EQRX
2590
DELISTED
EQRx, Inc. Common Stock
EQRX
$0 ﹤0.01%
20
CELL
2591
DELISTED
PhenomeX Inc. Common Stock
CELL
$0 ﹤0.01%
+100
New +$524
INFI
2592
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$0 ﹤0.01%
200
FOCS
2593
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$0 ﹤0.01%
10
AMRS
2594
DELISTED
Amyris Inc.
AMRS
$0 ﹤0.01%
200
NMTR
2595
DELISTED
9 Meters Biopharma
NMTR
$0 ﹤0.01%
50
+15
+43% +$141
TTCF
2596
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
-325
Closed -$4K
RXDX
2597
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-133
Closed -$5K
MTVC
2598
DELISTED
Motive Capital Corp II
MTVC
$0 ﹤0.01%
15
MTVC.WS
2599
DELISTED
Motive Capital Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
MTVC.WS
$0 ﹤0.01%
5
PSPC
2600
DELISTED
Post Holdings Partnering Corporation
PSPC
$0 ﹤0.01%
18

Similar funds

TCI Wealth Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, TCI Wealth Advisors held 2,649 positions worth $654M, down 2.1% from $667M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

TCI Wealth Advisors deployed $90.3M of net new capital in Q2 2022, opening 341 new positions and adding to 678 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 1,881,030 shares worth $59.4M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $3.32M trimmed.

  • TCI Wealth Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 1,881,030 shares worth $59.4M.
  • TCI Wealth Advisors added most to iShares Core US Aggregate Bond ETF in Q2 2022, an estimated $9.51M increase.
  • TCI Wealth Advisors's biggest Q2 2022 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $3.32M.
  • TCI Wealth Advisors fully exited Avantis US Large Cap Value ETF in Q2 2022, selling an estimated $65K.
  • TCI Wealth Advisors's ten largest holdings make up 62% of its $654M portfolio in Q2 2022.
  • TCI Wealth Advisors opened 341 new positions and closed 269 in Q2 2022.
  • TCI Wealth Advisors's portfolio value fell 2.1% quarter-over-quarter to $654M.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.